Skip to main content

Compugen Ltd. (CGEN)

NASDAQ: CGEN · IEX Real-Time Price · USD
4.50 -0.04 (-0.88%)
Nov 29, 2021 1:16 PM EST - Market open

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Net Income
-29.7-27.34-22.6-37.07-31.51-20.16-11.09-14.08-13.63-12
Depreciation & Amortization
0.720.991.391.591.481.110.660.370.30.18
Share-Based Compensation
2.772.412.172.633.083.773.633.542.473.4
Other Operating Activities
-2.11-3.955.752.187.12-10.32-4.353.730.01-0.82
Operating Cash Flow
-28.32-27.89-13.29-30.66-19.82-25.61-11.15-6.44-10.85-9.25
Capital Expenditures
-0.120.23-0.16-0.39-2.6-3.12-1.9-0.33-1.01-0.1
Change in Investments
-82.055.1-3546.6618.8113.42-62.09-11.2513.31-1.18
Other Investing Activities
000000-0.10-0.040.05
Investing Cash Flow
-82.175.33-35.1646.2816.2110.3-64.09-11.5812.26-1.23
Share Issuance / Repurchase
108.4625.9328.40.22.460.9772.1325.398.112.02
Other Financing Activities
0000000517
Financing Cash Flow
108.4625.9328.40.22.460.9772.1330.399.119.02
Net Cash Flow
-2.033.37-20.0515.82-1.15-14.33-3.1112.3810.53-1.45
Free Cash Flow
-28.44-27.66-13.45-31.04-22.42-28.73-13.04-6.77-11.85-9.35
Free Cash Flow Margin
-1422.10%--75.54%--3148.60%-309.66%-105.47%-190.67%-4897.11%-
Free Cash Flow Per Share
-0.36-0.43-0.24-0.61-0.44-0.57-0.27-0.17-0.33-0.27
Showing 10 of 21 years
11 more years are available
Start Free Trial
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).